Studsvik AB (publ) (SVIK) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Studsvik Q1 2026 conference call. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to the speakers, President and CEO Carl Dedean and CFO Peter Tesk. Please go ahead. Thank you very much and welcome to our Q2 earnings call for 2026. I'll typically start by just explaining the basis of the company. This is our financial figures for 2025. We are roughly 100 million dollars in revenue. We operate in 15 countries, meaning that we have customers in 15 plus countries. We are more than 500 people worldwide and we have offices in six countries. Our main markets are Nordics, continental Europe, UK, Canada and the US, Korea and Japan. Continue also to remind us about our key offerings and actually the key markets we operate in. If you start at the bottom right hand corner, you see life science. This is an emerging area for us. We have been in this area for quite some time now, but we see a lot of new developments in managing and handling highly radioactive isotopes for production purposes going into healthcare equipment, but also other industrial applications will require our competence and facilities. The main markets that we operate in are long-term operation and decommissioning. And long-term operation is all about serving the existing 440, or roughly there are 440 plants in the world, and we are actively supporting more than 200 of these. And that is both ongoing operation, but also securing lifetime extensions. In decommissioning, we are active mainly in Germany and then also in Switzerland, Benelux, and then in the Nordics. This is to safely both support ou...